Back to
STATE STREET CORP
ACRV14 quarters
Position history for
STATE STREET CORP's holdings in ACRIVON THERAPEUTICS INC
Yes. State Street holds 67,145 shares of ACRV (Acrivon Therapeutics), worth $119,518, as of its Q2 2026 13F filing. The share count is unchanged from Q1 2026. State Street has held ACRV since Q1 2023, across 14 quarterly 13F filings.
Current Value
$119,518
Current Shares
67,145
Total Value Change
-$963,434
Total Shares Change
-18,194
Quarter-by-Quarter History
Other major holders of ACRV: RA CAPITAL MANAGEMENT, L.P.